Overview
Team
Research Topics
Publications
Contact Us
Our Publications
The publications of this laboratory
(1) Topic 1. Parathyroid tumorigenesis
(2) Topic 2. Bone metabolism
(3) Topic 3. Endocrinology
(2) Dozio E, Passeri E, Cardani R, benedini S, Aresta C, Valaperta R, Corsi Romanelli M, Meola G, Sansone V, Corbetta S.
Circulating irisin is reduced in male patients with type 1 and type 2 myotonic dystrophies.
Front Endocrinol (Lausanne) 2017 Nov 14;8:320.
IF 3.675
(1) Verdelli C, Avagliano L, Guarnieri V, Cetani F, Ferrero S, Vicentini L, Beretta E, Scillitani A, Creo P, Bulfamante GP, Vaira V, Corbetta S.
Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors.
Lab Invest. 2017;97:1488-1499.
IF 4.857
(3) Bonomi M, Vezzoli V, Krausz C, Guizzardi F, Vezzani S, Simoni M, Bassi I, Duminuco P, Di Iorgi N, Giavoli C, Pizzocaro A, Russo G, Moro M, Fatti L, Ferlin A, Mazzanti L, Zatelli MC, Cannavò S, Isidori AM, Pincelli AI, Prodam F, Mancini A, Limone P, Tanda ML, Gaudino R, Salerno M, Francesca P, Maghnie M, Maggi M, Persani L; Italian Network on Central Hypogonadism.
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH).
Eur J Endocrinol. 2018;178:23-32.
IF 4.101
(3) Benedini S, Grassi G, Aresta C, Tufano A, Carmignani LF, Rubino B, Luzi L, Corbetta S.
Adrenal ganglioneuroblastoma in adults: a case report and review of the literature.
Case Rep Endocrinol 2017;2017:5796236.
(2) Mantovani G, Elli F, Corbetta S.
Hypothyroidism associated with parathyroid disorders.
Best Pract Res Clin Endocrinol Metab 2017;31:161-173.
IF 4.466
(1) Guarnieri V, Muscarella LA, Verdelli C, Corbetta S.
Alterations of DNA methylation in parathyroid tumors.
Mol Cell Endocrinol 2017 May 10 [Epub ahead of print]
IF 3.859
(3) Morelli V, Palmieri S, Lania A, Tresoldi A, Corbetta S, Cairoli E, Eller-Vainicher C, Arosio M, Copetti M, Grossi E, Chiodini I.
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks.
Eur J Endocrinol 2017 May 3 [Epud ahead of print].
IF 4.101
(1) Verdelli C, Corbetta S.
Epigenetic alterations in parathyroid cancers.
Int J Mol Sci 2017;18.pii:E310.
IF 3.257
(3) Peverelli E, Giardino E, Treppiedi D, Meregalli M, Belicchi M, Vaira V, Corbetta S, Verdelli C, Verrua E, Serban AL, Locatelli M, Carrabba G, Gaudenzi G, Malchiodi E, Cassinelli L, Lania AG, Ferrero S, Bosari S, Vitale G, Torrente Y, Spada A, Mantovani G.
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from non-functioning pituitary tumors.
Int J Cancer 2017;140:1870-1880.
IF 5.531
(1) Mingione A, Verdelli C, Ferrero S, Vaira V, Guarnieri V, Scillitani A, Vicentini L, Balza G, Beretta E, Terranegra A, Vezzoli G, Soldati L, Corbetta S.
Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors.
J Mol Endocrinol 2017;58:91-103.
IF 2.947
(1) Vaira V, Verdelli C, Forno I, Corbetta S.
MicroRNAs in parathyroid physiopathology.
Mol Cell Endocrinol 2016 Nov 2 [Epub ahead of print].
IF 3.859
(3) Mauri G, Cova L, Monaco CG, Sconfienza LM, Corbetta S, Benedini S, Ambrogi F, Milani V, Baroli A, Ierace T, Solbiati L.
Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA).
Int J Hyperthermia 2016 Nov 15:1-5 [Epub ahead of print].
IF 3.361
(2) Verdelli C, Corbetta S.
Mechanism in endocrinology: kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects.
Eur J Endocrinol 2017;176:R39-R52.
IF 3.892
(2) Morelli V, Eller-Vainicher C, Palmieri S, Cairoli E, Salcuni SA, Scillitani A,Carnevale V, Corbetta S, Arosio M, Della Casa S, Muscogiuri G, Spada A, Chiodini I.
Prediction of vertebral fractures in patients with monolateral adrenal incidentalomas.
J Clin Endocrinol Metab 2016;101:2768-2775.
IF 6.31
(2) Passeri E, Rigolini R, Costa E, Verdelli C, Arcidiacono C, Carminati M, Corbetta S.
Serum NT-proBNP levels are not related to vitamin D status in young patients with congenital heart defects.
Dis Markers 2016;2016:3970284.
IF 2.137
(1) Sanpaolo E, Miroballo M, Corbetta S, Verdelli C, Baorda F, Balsamo T, Graziano P, Fabrizio FP, Cinque L, Scillitani A, Muscarella LA, Guarnieri V.
EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
Endocrine 2016 Feb 15 [Epub ahead of print].
IF 3.279
(3) De Filippis T, Marelli F, Nebbia G, Porazzi P, Corbetta S, FugazzolaL, gastaldi R, Vigone MC, Biffanti R, Frizziero D, Mandarà L, Prontera P, Salerno M, Maghnie M, Tiso N, Radetti G, Weber G, Persani L.
JAG1 loss-of-function variations as a novel predisposing event in the pathogenesis of congenital thyroid defects.
J Clin Endocrinol Metab 2016;101:861-870.
IF 6.31
(2) Passeri E, Dozio E, Mendola M, Costa E, Bandera F, Corsi Romanelli MM, Corbetta S.
Treatment with teriparatide might be associated with cardiometabolic changes in postmenopausal severe osteoporotic women.
J Biol Regul Homeost Agents 2015;29:931-940.
IF 2.406
(2) Ermetici F, Filopanti M, Verga U, Passeri E, Dito G, Malavazos AE, Mapelli C, Raggi ME, Spada A, Corbetta S.
Estimated glomerular filtration rate by serum cystatin C correlates with
cardiometabolic parameters in patients with primary hyperparathyroidism.
Eur J Endocrinol 2015;173:441-446.
IF 3.892
(2) Capelli S, Donghi V, Maruca K, Vezzoli G, Corbetta S, Brandi ML, Mora S, Weber G.
Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets.
Bone 2015;79:143-149.
IF 3.736
(2) Simon I, Roumeguere T, Devuyst F, Cotton F, Tang BN, Cappello M, Corbetta S, Idrissi M, Pozdzik A, Nortier J.
[Recurrent episodes of brushite nephrolithiasis revealing primary hyperparathyroidism].
Rev Med Brux 2015;36:172-176.
(1) Mingione A, Verdelli C, Terranegra A, Soldati L, Corbetta S.
Molecular and clinical aspects of the target therapy with the calcimimetic cinacalcet in the treatment of parathyroid tumors.
Curr Cancer Drug Targets 2015;15:563-574.
IF 3.707
(2) Passeri E, Bugiardini E, Sansone VA, Pizzocaro A, Fulceri C, Valaperta R, Borgato S, Costa E, Bandera F, Ambrosi B, Meola G, Persani L, Corbetta S.
Gonadal failure is associated with visceral adiposity in myotonic dystrophies.
Eur J Clin Invest 2015;45:702-710.
IF 2.687
(2) Passeri E, Benedini S, Costa E, Corbetta S.
A single 60 mg dose of denosumab might improve hepatic insulin sensitivity in postmenopausal nondiabetic severe osteoporotic women.
Int J Endocrinol 2015;2015:352858.
IF 2.376
(3) Benedini S, Tufano A, Passeri E, Mendola M, Luzi L, Corbetta S.
Autoimmune polyendocrine syndrome 3 onset with severe ketoacidosis in a 74-year-old woman.
Case Rep Endocrinol 2015;2015:960615.
(3) Caruso R, Santucci A, Caruso MP, Pittella F, Dellafiore F, Corbetta S, Mosconi E.
Physical activity, dietary habits, and cognitive decline in over 65 years Italian outpatients with type 2 diabetes: a cross-sectional pilot study.
International Diabetes Nursing 2015; 1-5.
(2) Marcocci C, Brandi ML, Scillitani A, Corbetta S, Faggiano A, Gianotti L, Migliaccio S, Minisola S.
Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
J Endocrinol Invest 2015;38:577-593.
IF 1.994
(1) Verdelli C, Forno I, Vaira V, Corbetta S.
Epigentic alterations in human parathyroid tumors.
Endocrine 2015;49:324-332.
IF 3.279
(1) Verdelli C, Forno I, Vaira V, Corbetta S.
MicroRNA deregulation in parathyroid tumours suggests an embryonic signature.
J Endocrinol Invest 2015;38:383-388.
IF 1.994
(1) Verdelli C, Avagliano L, Creo P, Guarnieri V, Scillitani A, Vicentini L, Steffano GB, Beretta E, Soldati L, Costa E, Spada A, Bulfamante G, Corbetta S.
Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia.
Endocr Relat Cancer 2015;22:87-98.
IF 4.472
(1) D’Agruma L, Coco M, Guarnieri V, Battista C, Canaff L, Salcuni AS, Corbetta S, Cetani F, Minisola S, Chiodini I, Eller-Vainicher C, Spada A, Marcocci C, Guglielmi G, Zini M, Clemente R, Wong BY, de Martino D, Scillitani A, Hendy GN, Cole DE.
Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.
J Clin Endocrinol Metab 2014;99:E2974-2978.
IF 6.31
(3) Passeri E, Bonomi M, Dangelo F, Persani L, Corbetta S.
Wasting syndrome with deep bradycardia as presenting manifestation of long-standing severe male hypogonadotropic hypogonadism: a case series.
BMC Endocr Disord 2014;14:78.
IF 1.739
(3) Massironi S, Rossi RE, Ferrero S, Cavalcoli F, Spampatti MP, Conte D, Corbetta S, Peracchi M.
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma: an unusual association and review of the literature.
J Cancer Res Ther 2014;10:443-445.
IF 0.79
(2) Eller-Vainicher C, Battista C, Guarnieri V, Muscarella S, Palmieri S, Salcuni AS, Guglielmi G, Corbetta S, Minisola S, Spada A, Hendy GN, Cole DE, Chiodini I, Scillitani A.
Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism.
Eur J Endocrinol 2014;171:399-406.
IF 3.892
(2) Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliottti E, Guarnieri V, Arcidiacono T, Macrina L, Mingione A, Brasacchio C, Eller-Vainicher C, Cusi D, Spada A. Cole DE, Hendy GN, Spotti D, Soldati L.
Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene.
J Nephrol 2014 May 16 [Epub ahead of print].
IF 1.352
(3) Mendola M, Passeri E, Ambrosi B, Corbetta S.
Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
J Clin Endocrinol Metab 2014;99:2623-2624.
IF 6.31
(3) Mendola M, Dolci A, Piscopello L, Tomei G, Bauer D, Corbetta S, Ambrosi B.
Rare case of Cushing’s disease due to double ACTH-producing adenomas, one located in the pituitary gland and one into the stalk.
Hormones (Athens) 2014; 13:1-5.
IF 1.10
(1) Filopanti M, Corbetta S, Barbieri AM, Spada A.
Pharmacology of the calcium sensing receptor.
Clin Cases Miner Bone Metab 2013;10:162-165.
(3) Passeri E, Sansone VA, Verdelli C, Mendola M, Corbetta S.
Asymptomatic myotonia congenital unmasked by severe hypothyroidism.
Neuromuscol Disord 2014;24:365-367.
IF 3.107
(3) Libri DV, Kleinau G, Vezzoli V, Busnelli M, Guizzardi F, Sinisi AA, Pincelli AI, Mancini A, Russo G, Beck-Peccoz P, Loche S, Crivellaro C, Maghnie M, Krausz C, Persani L, Bonomi M; Italian Study Group on Idiopathic Central Hypogonadism (IHC).
Germline prokineticin receptor 2 (PROKR2) variants associated eith central hypogonadism cause differential modulation distinct intracellular pathways.
Journal of Endocrinology and Metabolism 2014;99:E458-463.
IF 6.31
(3) Filopanti M, Barbieri AM, Mantovani G, Corbetta S, Gasco V, Ragonese M, Martini C, Bogazzi F, Colao AA, Ferone D, Peri A, Pigliaru F, Angeletti G, Arosio M, Beck-Peccoz P, Lania A, Spada A.
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients.
Eur J Endocrinol 2013;170:247-254.
IF 3.892
(3) Peverelli E, Ermetici F, Corbetta S, Gozzini E, Avagliano L, Zappa MA, Bulfamante G, Beck-Peccoz P, Spada A, Mantovani G.
PKA regulatory subunit R2B is required for murine and human adipocyte differentiation.
Endocr Connect 2013;2:196-207.
(2) Passeri E, Bugiardini E, Sansone VA, Valaperta R, Costa E, Ambrosi B, Meola G, Corbetta S.
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies.
J Neurol Sci 2013;331:132-5.
IF 2.126
(1) Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D’Agruma L, Chiodini I, Clemente C, Minisola S, Romagnoli E, Corbetta S, Viti R, Eller-Vainicher C, Spada A, Iacobellis M, Malavolta N, Carella M, Canaff L, Hendy GN, Cole DE, Scillitani A.
CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient color.
Cell Oncol (Dordr). 2012;35:411-422.
IF 3.562
(3) Bonomi M, Somigliana E, Cacciatore C, Busnelli M, Rossetti R, Bonetti S, Paffoni A, Mari D, Ragni G, Persani L; the Italian Network for the study of Ovarian Dysfunctions.
Blood cell mitochondrial DNA content and premature ovarian aging.
Plos One 2012;7:e42423.
IF 3.54
(1) Vaira V, Elli F, Forno I, Guarnieri V, Verdelli C, Ferrero S, Scillitani A, Vicentini L, Cetani F, Mantovani G, Spada A, Bosari S, Corbetta S.
The microRNA cluster C19MC is deregulated in parathyroid tumours.
J Mol Endocrinol 2012;49:115-124.
IF 2.947
(3) Bonomi M, Libri D, Guizzardi F, Guarducci E, Maiolo E, Pignatti E, Asci R, Persani L; Idiopathic Central Hypogonadism Study Group of the Italian Societies of Endocrinology and Pediatric Endocrinology and Diabetes.
New understandings of the genetic basis of isolated idiopathic central hypogonadism.
Asian J Androl 2012;14:49-56.
IF 2.644
(2) Filopanti M, Verga U, Ermetici F, Olgiati L, Eller-Vainicher C, Corbetta S, Persani L, Beck-Peccoz P, Spada A.
MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
Eur J Endocrinol 2012;167:157-164.
IF 3.892
(3) Passeri E, Tufano A, Perrotta S, Ambrosi B, Corbetta S.
Variable clinical presentations in a family with neurohypophysial diabetes insipidus.
J Endocrinol Invest 2011; 34:889-890.
IF 1.994
(3) Filopanti M, Olgiati L, Mantovani G, Corbetta S, Arosio M, Gasco V, De Marinis L, Martini C, Bogazzi F, Cananvò S, Colao A, Ferone D, Arnaldi G, Pigliaru F, Peri A, Angeletti G, Jaffrain-Rea ML, Lania AG, Spada A.
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalia patients: a multi center study.
J Clin Endocrinol Metab 2012;97:E165-172.
IF 6.31
(3) Ferrante E, Malavazos AE, Giavoli C, Ermetici F, Coman C, Bergamaschi S, Profka E, Briganti S, Ronchi CL, Passeri E, Corbetta S, Lania AG, Spada A, Iacobellis G, Ambrosi B, Beck-Peccoz P.
Epicardial fat thickness significantly decreases after sgort-term growth hormone (GH) replacement therapy in adults with GH deficiency.
Nutr Metab Cardiovasc Dis. 2013;23:459-465.
IF 3.39
(1) Guarnieri V, Baorda F, Battista C, Bisceglia M, Balsamo T, Gruppioni E, Fiorentino M, Muscarella LA, Coco M, Barbano R, Corbetta S, Spada A, Cole DE, Canaff L, Hendy GN, Carella M, Scillitani A.
A rare S33C mutation of CTNNB1 encoding b-catenin in a parathyroid adenoma found in an Italian primay hyperparathyroid color.
Endocrine 2012;41:152-155.
IF 3.42
(1) Frigerio M, Passeri E, De Filippis T, Rusconi D, Valaperta R, Carminati M, Donnangelo A, Costa E, Persani L, Finelli P, Corbetta S.
SNPs and real-time quantitative PCR method for constitutional allelic copy number determination, the VPREB1 marker case.
BMC Med Genet 2011;12:61.
IF 2.094
(3) Corbetta S, Redaelli A, Pozzi M, Bovo G, Ratti L, Redaelli E, Pellegrini C, Beck-Peccoz P, Spada A.
Fibrosis is associated with adiponectin resi stance in chronic hepatitis C virus infection.
Eur J Clin Invest 2011;41:898-905.
IF 2.73
(3) Passeri E, Frigerio M, De Filippis T, Valaperta R, Capelli P, Costa E, Fugazzola L, Marelli F, Porazzi P, Arcidiacono C, Carminati M, Ambrosi B, Persani L, Corbetta S.
Increased risk for non-autoimmune hypothyroidism in young patients with congenital heart defects.
J Clin Endocrinol Metab 2011;96:E1115-1119.
IF 6.31
(3) Passeri E, Frigerio M, Valaperta R, Costa E, Ambrosi B, Corbetta S.
Adult onset hypoparathyroidism in a patient with psychiatric illness: a 71 years delayed diagnosis of DiGeorge syndrome.
J Endocrinol Invest 2010;33:852-853.
IF 1.994
(3) Passeri E, Tufano A, Locatelli M, Lania AG, Ambrosi B, Corbetta S.
Large pituitary hyperplasia in severe primary hypothyroidism.
J Clin Endocrinol Metab 2011;96:22-23.
IF 6.31
(2) Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliotti E, Guarnieri V, Arcidiacono T, Paloschi V, Rainone F, Eller-Vainicher C, Borghi L, Nouvenne A, Guerra A, Meschi T, Allegri F, Cusi D, Spada A, Cole DE, Hendy GN, Spotti D, Soldati L.
Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism.
Eur J Endocrinol 2011;164:421-427.
IF 3.892
(3) Corbetta S, Muzza M, Avagliano L, Bulfamante G, Gaetti L, Eller-Vainicher C, Beck-Peccoz P, Spada A.
Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Mullerian derivatives: comparison with normal fetal development.
Fertil Steril 2011;95:1119.e9-14.
IF 4.426
(1) Terranegra A, Ferraretto A, Dogliotti E, Scarpellini M, Corbetta S, Barbieri AM, Spada A, Arcidiacono T, Rainone F, Aloia A, Cusi D, Vezzoli G, Soldati L.
Calcimimetic R-568 effects on activity of R990G polymorphism of calcium-sensing receptor.
J Mol Endocrinol 2010;45:245-256.
IF 2.947
(3) Giavoli C, Ferrante E, Profka E, Olgiati L, Bergamaschi S, Ronchi CL, Verrua E, Filopanti M, Passeri E, Montefusco L, Lania AG, Corbetta S, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P.
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy.
Eur J Endocrinol 2010;163:361-368.
IF 3.892
(1) Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S, Spada A.
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
Endocrine-Related Cancer 2010;17:1-13.
IF 4.432
(1) Corbetta S, Belicchi M, Pisati F, Meregalli M, Eller-Vainicher C, Vicentini L, Beck-Peccoz P, Spada A, Torrente Y.
Expression of parathyroid specific genes in vascular endothelial progenitors of normal and tumoral parathyroids.
Am J Pathol 2009;175:1200-1207.
IF 4.206
(3) Ermetici F, Donadio F, Iorio L, Malavazos AE, Dolci A, Peverelli E, Barbieri AM, Morricone L, Chiodini I, Arosio M, Lania A, Beck-Peccoz P, Ambrosi B, Corbetta S.
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function.
Eur J Endocrinol 2009;161:1-8
IF 3.892
(2) Corbetta S, Eller-Vainicher C, Vicentini L, Carnicelli S, Sardanelli F, Beck-Peccoz P, Spada A.
High prevalence of simple kidney cysts in patients with primary hyperparathyroidism.
J Endocrinol Invest 2009;32:690-694.
IF 1.994
(3) Mantovani G, Corbetta S, Bondioni S, Menicanti L, Rubino B, Peverelli E, Labarile P, Dall’Asta C, Ambrosi B, Beck-Peccoz P, Lania AG, Spada A.
Analysis of GNAS and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders.
J Endocrinol Invest 2009;32:501-504.
IF 1.994
(3) Ronchi CL, Giavoli C, Ferrante E, verrua E, Bergamaschi S, Ferrari DI, Corbetta S, Montefusco L, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P.
Prevalence of growth hormone deficiency (GHD) in cured acromegalic patients: impact of different previous treatments.
Eur J Endocrinol 2009;161:37-42
IF 3.892
(2) Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, Peracchi M, D’Agruma L, Minisola S, Corbetta S, Spada A, Scillitani A.
Sporadic and MEN1 related primary hyperparathyroidism: differences in clinical expression and severity.
J Bone Miner Res 2009;24:1404-1410.
IF 5.622
(3) Mantovani G, Bondioni S, Alberti L, Gilardini L, Invitti C, Corbetta S, Zappa M, Ferrero S, Lania A, Bosari S, Beck-Peccoz P, Spada A.
Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects.
Diabetes 2009;58:620-626.
IF 8.095
(2) Corbetta S, Eller-Vainicher C, Frigerio M, Valaperta R, Costa E, Vicentini L, Baccarelli A, Beck-Peccoz P, Spada A.
Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl–oxalate transporter in patients with primary hyperparathyroidism.
Eur J Endocrinol. 2009;160:283-288.
IF 3.892
(3) Ermetici F, Malavazos AE, Corbetta S, Eller-Vainicher C, Cannavò S, Corsi MM, Ambrosi B.
Soluble adhesion molecules levels in patients with Cushing’s syndrome before and after cure.
J Endocrinol Invest 2008;31:389-392.
IF 1.994
(3) Bondioni S, Angioni AR, Corbetta S, Locatelli M, Ferrero S, Ferrante E, Mantovani G, Olgiati L, Beck-Peccoz P, Spada A, Lania AG.
Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells.
Exp Biol Med (Maywood) 2008;233:439-446.
IF 2.542
(2) Mantovani G, Bondioni S, Linglart A, Maghnie M, Cisternino M, Corbetta S, Lania AG, Beck-Peccoz P, Spada A.
Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib.
J Clin Endocrinol Metab 2007;92:3738-3742
IF 6.31
(3) Ronchi CL, Peracchi M, Corbetta S, Massironi S, Ciafardini C, Conte D, Beck-Peccoz P, Spada A.
Evaluation of IGF-I levels during long-term somatostatin analogs treatment in patients with gastroenteropancreatic endocrine tumors.
J Endocrinol Invest 2007;30:241-246
IF 1.994
(1) Corbetta S, Eller-Vainicher C, Vicentini L, Lania A, Mantovani G, Beck-Peccoz P, Spada A.
Modulation of cyclin D1 expression in human tumoral parathyroid cells: effects of growth factors and calcium sensing receptor activation.
Cancer Letters 2007;255:34-41
IF 5.992
(3) Ermetici F, Malavazos AE, Corbetta S, Morricone L, Dall’Asta C, Corsi MM, Ambrosi B.
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma.
Metabolism Clinical and Experimental 2007; 56: 686-692.
IF 4.375
(3) Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A.
Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies.
Clin Endocrinol 2007;66:447-453.
IF 3.487
(2) Corbetta S, Eller-Vainicher C, Filopanti M, Saeli P, Vezzoli G, Arcidiacono T, Loli P, Syren ML, Soldati L, Beck-Peccoz P, Spada A.
R990G Polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism.
Eur J Endocrinol 2006;155:1-7.
IF 3.892
(3) Corbetta S, Angioni R, Cattaneo A, Beck-Peccoz P, Spada A.
Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines.
Eur J Endocrinol 2006;154:83-86.
IF 3.892
(1) Corbetta S, Vicentini L, Ferrero S, Lania A, Mantovani G, Cordella D, Beck-Peccoz P, Spada A.
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors.
Endocr Relat Cancer 2005;12:929-937.
IF 4.42
(3) Mantovani G, Bondioni S, Ferrero S, Gamba B, Ferrante E, Peverelli E, Corbetta S, Locatelli M, Rampini P, Beck-Peccoz P, Spada A, Lania AG.
Effect of cyclic adenosine 3′,5′-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas.
J Clin Endocrinol Metab 2005;90:6721-6724.
IF 6.31
(3) Corbetta S, Bulfamante G, Cortelazzi D, Barresi V, Cetin I, Mantovani G, Bondioni S, Beck-Peccoz P, Spada A.
Adiponectin expression in human fetal tissues durino mid- and late gestation.
J Clin Endocrinol Metab 2005;90:2397-2402.
IF 6.31
(2) Corbetta S, Baccarelli A, Aroldi A, Vicentini L, Fogazzi GB, Eller-Vainicher C, Ponticelli C, Beck-Peccoz P, Spada A.
Risk factors associated to kidney stones in primary hyperparathyroidism.
J Endocrinol Invest 2005;28:122-126.
IF 1.994
(3) Giavoli C, Libè R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A, Beck-Peccoz P.
Effect of recombinant human GH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH deficient patients.
J Clin Endocrinol Metab 2004;89:5397-5401.
IF 6.31
(3) Giavoli C, Cappiello V, Corbetta S, Ronchi CL, Morpurgo PS, Ferrante E, Beck-Peccoz P, Spada A.
Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
Clin Endocrinol (Oxf) 2004;61:81-87.
IF 3.487
(3) Lania A, Mantovani G, Zavanone LM, Locatelli M, Corbetta S, Beck-Peccoz P, Spada A.
Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas
J Endocrinol Invest 2004;27:328-333
IF 1.994
(3) Mantovani G, Bondioni S, Lania A, Corbetta S, De Sanctis L, Cappa M, Di Benedetto E, Chanson P, Beck-Peccoz P, Spada A.
Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors.
J Clin Endocrinol Metab 2004;89:3007-3009.
IF 6.31
(3) Ronchi CL, Corbetta S, Cappiello V, Morpurgo PS, Giavoli C, Beck-Peccoz P, Arosio M, Spada A.
Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients.
Eur J Endocrinol. 2004;150:663-669.
IF 3.892
(3) Lania A, Filopanti M, Corbetta S, Ballarè E, Losa M, Beck-Peccoz P, Spada A.
Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells.
J Clin Endocrinol Metab 2003;88:1692-1696.
IF 6.31
(3) Corbetta S, Peracchi M, Cappiello V, Lania A, Lauri E, Vago L, Beck-Peccoz P, Spada A.
Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma.
J Clin Endocrinol Metab 2003;88:3117-3120.
IF 6.31
Questo articolo è stato selezionato per essere pubblicato come abstract nel YEAR BOOK OF ENDOCRINOLOGY 2004.
(2) Corbetta S, Rossi D, D’Orto O, Vicentini L, Beck-Peccoz P, Spada A.
Brown jaw tumors: a today unusual presentation of primary hyperparathyroidism.
J Endocrinol Invest 2003;26:675-678.
IF 1.994
(3) Peracchi M, Conte D, Gebbia C, Penati C, Pizzinelli S, Arosio M, Corbetta S, Spada A.
Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
Eur J Endocrinol 2003;148:39-43.
IF 3.892
(1) Corbetta S, Lania A, Filopanti M, Vicentini L, Ballarè E, Spada A.
Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells.
J Clin Endocrinol Metab. 2002;87:2201-2205.
IF 6.31
(3) Morpurgo PS, Corsi A, Corbetta S, Vicentini L, Spada A.
In vitro release of activin A from human normal and pathological thyroid tissues.
J Endocrinol Invest. 2001;24:RC25-27.
IF 1.994
(3) Ballarè E, Persani L, Lania AG, Filopanti M, Giammona E, Corbetta S, Mantovani S, Arosio M, Beck-Peccoz P, Faglia G, Spada A.
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment.
J Clin Endocrinol Metab. 2001;86:3809-3814.
IF 6.31
(1) Mantovani G, Corbetta S, Romoli R, Alberti L, Beck-Peccoz P, Spada A.
Absence of thyroid transcription factor-1 expression in human parathyroid and pituitary glands.
Mol Cell Endocrinol. 2001;182:13-17.
IF 4.41
(3) Peri A, Conforti B, Baglioni-Peri S, Luciani P, Cioppi F, Buci L, Corbetta S, Ballare E, Serio M, Spada A.
Expression of cyclic adenosine 3’,5’-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
J Clin Endocrinol Metab. 2001;86:2111-2117.
IF 6.31
(3) Corbetta S, Ballare E, Mantovani G, Lania A, Losa M, Di Blasio AM, Spada A.
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
Eur J Clin Invest. 2001;31:208-214.
IF 2.73
(2) Castellani M, Reschini E, Longari V, Paracchi A, Corbetta S, Marotta G, Gerundini P.
Role of Tc-99m sestamibi scintigraphy in the diagnosis and surgical decision-making process in primary hyperparathyroid disease.
Clin Nucl Med. 2001;26:139-144.
IF 3.93
(1) Corbetta S, Mantovani G, Lania A, Borgato S, Vicentini L, Beretta E, Faglia G, Di Blasio AM, Spada A.
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Clin Endocrinol (Oxf) 2000;52:339-348.
IF 3.487
(3) Romoli R, Lania A, Mantovani G, Corbetta S, Persani L, Spada A.
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas.
J Clin Endocrinol Metab. 1999;84:2848-2853.
IF 6.31
(3) Lania A, Ballarè E, Corbetta S, Filopanti M, Persani L, Spada A.
Growth hormone-releasing hexapeptide (GHRP-6) increases intracellular calcium concentrations in cultured cells from human pituitary adenomas of different types.
Eur J Endocrinol. 1998;139:343-348.
IF 4.101
(3) Corbetta S, Englaro P, Giambona S, Persani L, Blum WF, Beck-Peccoz P.
Lack of effects of circulating thyroid hormone levels on serum leptin concentrations.
Eur J Endocrinol. 1997;137:659-663.
IF 4.101
(2) Corbetta S, Pizzocaro A, Peracchi M, Beck-Peccoz P, Faglia G, Spada A.
Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types.
Clin Endocrinol (Oxf) 1997;47:507-512.
IF 3.487